Psychopharmacology and Addiction Research Centre (PARC)
The Psychopharmacology and Addiction Research Centre (PARC) at the University of Exeter investigates the impact of drugs acutely and chronically on the human brain and behaviour. We use a range of approaches to tackle questions and develop new treatments for addiction.
For enquiries about the KARE trial email: kare@exeter.ac.uk.
For all other enquiries please email: a.mcandrew@exeter.ac.uk.
About us
Our translational methods aim to see new pharmacotherapies right through from bench to bedside. Affiliated with the world-leading Mood Disorders Centre in University of Exeter, we are also interested in co-morbidity between substance abuse and mood disorders. And as psychopharmacologists amongst psychologists we also are investigating the synergistic use of pharmacological and psychological therapies
We collaborate with a variety of medical professionals including anaesthetists and psychiatrists from the Royal Devon and Exeter Partnership Trust. We have also strong links with local drug and alcohol service providers formalised in our Exeter Translational Addiction Partnership (ETAP).
Type of research
- Psychopharmcology
- Neuroimaging
- EEG
- Sleep studies
- Naturalistic studies
- Clinical Trials
Facilities
We have 2 dedicated labs in our research centre at the University’s St Luke’s campus.
We conduct studies in the NIHR Exeter Clinical Research facility which is a purpose built testing centre part of the Royal Devon and Exeter Hospital.
We have access to the psychophysiological recording equipment and virtual reality suite in the Mood Disorders Centre along with a 1.5T MRI scanner within the University of Exeter Medical School.